Vildaridge M 50/1000
TM Tablets combine Vildagliptin with a higher dose of Metformin to provide enhanced glycemic control in patients with type 2 diabetes mellitus. Vildagliptin improves incretin activity, promoting insulin secretion and reducing glucagon levels, while Metformin (1000 mg) offers stronger control over hepatic glucose production and improves insulin sensitivity. This formulation is suitable for patients who require tighter glucose regulation as their condition progresses.
Composition
- Vildagliptin 50 mg
- Metformin Hydrochloride 1000 mg
Key Features & Benefits
- Stronger Glycemic Reduction: Higher Metformin dose for improved blood glucose control
- Dual Mechanism Action: Combines incretin enhancement with insulin sensitization
- Effective for Progressive Cases: Suitable for patients needing dose escalation
- Low Hypoglycemia Risk: When used under proper medical supervision
- Convenient Combination Therapy: Reduces pill burden and supports adherence
Recommended Usage
- To be taken as prescribed by a healthcare professional
- Preferably taken with meals to minimize gastrointestinal side effects
- Regular monitoring of blood glucose levels is recommended
Safety Information
- Not recommended in patients with severe renal or hepatic impairment
- Monitor renal and liver function periodically
- Increased likelihood of gastrointestinal side effects due to higher Metformin dose
- Use under medical supervision and report any unusual symptoms
Storage Instructions
- Store in a cool and dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
